200 related articles for article (PubMed ID: 10506709)
1. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis.
Wang HH; Myers T; Lach LJ; Hsieh CC; Kadin ME
Cancer; 1999 Oct; 86(7):1240-5. PubMed ID: 10506709
[TBL] [Abstract][Full Text] [Related]
2. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
Wieser I; Oh CW; Talpur R; Duvic M
J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
[TBL] [Abstract][Full Text] [Related]
3. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases.
Nijsten T; Curiel-Lewandrowski C; Kadin ME
Arch Dermatol; 2004 Mar; 140(3):306-12. PubMed ID: 15023774
[TBL] [Abstract][Full Text] [Related]
4. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients.
Kunishige JH; McDonald H; Alvarez G; Johnson M; Prieto V; Duvic M
Clin Exp Dermatol; 2009 Jul; 34(5):576-81. PubMed ID: 19196298
[TBL] [Abstract][Full Text] [Related]
5. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.
Basarab T; Fraser-Andrews EA; Orchard G; Whittaker S; Russel-Jones R
Br J Dermatol; 1998 Oct; 139(4):630-8. PubMed ID: 10025972
[TBL] [Abstract][Full Text] [Related]
6. Three cases of lymphomatoid papulosis with a CD56+ immunophenotype.
Flann S; Orchard GE; Wain EM; Russell-Jones R
J Am Acad Dermatol; 2006 Nov; 55(5):903-6. PubMed ID: 17052504
[TBL] [Abstract][Full Text] [Related]
7. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients.
de Souza A; el-Azhary RA; Camilleri MJ; Wada DA; Appert DL; Gibson LE
J Am Acad Dermatol; 2012 Jun; 66(6):928-37. PubMed ID: 21982062
[TBL] [Abstract][Full Text] [Related]
8. Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma.
Heald P; Subtil A; Breneman D; Wilson LD
J Am Acad Dermatol; 2007 Dec; 57(6):1005-11. PubMed ID: 17919773
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
11. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
de la Garza Bravo MM; Patel KP; Loghavi S; Curry JL; Torres Cabala CA; Cason RC; Gangar P; Prieto VG; Medeiros LJ; Duvic M; Tetzlaff MT
Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
13. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
14. Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients.
de Souza A; Camilleri MJ; Wada DA; Appert DL; Gibson LE; el-Azhary RA
J Am Acad Dermatol; 2009 Dec; 61(6):993-1000. PubMed ID: 19577330
[TBL] [Abstract][Full Text] [Related]
15. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
16. Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.
Cordel N; Tressières B; D'Incan M; Machet L; Grange F; Estève É; Dalac S; Ingen-Housz-Oro S; Bagot M; Beylot-Barry M; Joly P;
Oncologist; 2016 Jan; 21(1):76-83. PubMed ID: 26668250
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Arch Dermatol; 2004 Apr; 140(4):441-7. PubMed ID: 15096372
[TBL] [Abstract][Full Text] [Related]
19. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
